nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—CYP1A2—Imiquimod—skin cancer	0.114	0.224	CbGbCtD
Ropinirole—CYP1A2—Vemurafenib—skin cancer	0.0625	0.123	CbGbCtD
Ropinirole—CYP3A4—Temozolomide—skin cancer	0.0598	0.117	CbGbCtD
Ropinirole—CYP3A4—Imiquimod—skin cancer	0.0598	0.117	CbGbCtD
Ropinirole—CYP2D6—Vemurafenib—skin cancer	0.0515	0.101	CbGbCtD
Ropinirole—CYP1A2—Dacarbazine—skin cancer	0.0479	0.0941	CbGbCtD
Ropinirole—CYP3A4—Vismodegib—skin cancer	0.0414	0.0814	CbGbCtD
Ropinirole—CYP3A4—Vemurafenib—skin cancer	0.0328	0.0643	CbGbCtD
Ropinirole—CYP1A2—Fluorouracil—skin cancer	0.0281	0.0552	CbGbCtD
Ropinirole—DRD5—eyelid—skin cancer	0.0185	0.286	CbGeAlD
Ropinirole—CYP3A4—Docetaxel—skin cancer	0.0112	0.0221	CbGbCtD
Ropinirole—DRD1—nerve—skin cancer	0.00377	0.0582	CbGeAlD
Ropinirole—HTR2A—hindlimb—skin cancer	0.00241	0.0373	CbGeAlD
Ropinirole—HTR1B—blood vessel—skin cancer	0.0024	0.037	CbGeAlD
Ropinirole—HTR1D—blood vessel—skin cancer	0.00232	0.0359	CbGeAlD
Ropinirole—DRD2—nerve—skin cancer	0.00222	0.0344	CbGeAlD
Ropinirole—HTR2A—appendage—skin cancer	0.00207	0.032	CbGeAlD
Ropinirole—HTR2A—nerve—skin cancer	0.00147	0.0227	CbGeAlD
Ropinirole—DRD5—lymphoid tissue—skin cancer	0.00145	0.0224	CbGeAlD
Ropinirole—DRD5—female reproductive system—skin cancer	0.0014	0.0216	CbGeAlD
Ropinirole—HTR2A—endothelium—skin cancer	0.00125	0.0193	CbGeAlD
Ropinirole—DRD3—head—skin cancer	0.00125	0.0193	CbGeAlD
Ropinirole—ADRA2C—nipple—skin cancer	0.00123	0.019	CbGeAlD
Ropinirole—HTR1D—connective tissue—skin cancer	0.00119	0.0184	CbGeAlD
Ropinirole—DRD5—head—skin cancer	0.00117	0.0181	CbGeAlD
Ropinirole—HTR2A—blood vessel—skin cancer	0.00115	0.0178	CbGeAlD
Ropinirole—CYP1A2—nipple—skin cancer	0.00107	0.0165	CbGeAlD
Ropinirole—HTR2B—skin of body—skin cancer	0.000999	0.0154	CbGeAlD
Ropinirole—ADRA2A—nipple—skin cancer	0.00098	0.0151	CbGeAlD
Ropinirole—DRD1—head—skin cancer	0.000893	0.0138	CbGeAlD
Ropinirole—HTR1B—female reproductive system—skin cancer	0.000866	0.0134	CbGeAlD
Ropinirole—HTR1D—female reproductive system—skin cancer	0.000839	0.013	CbGeAlD
Ropinirole—HTR2C—female reproductive system—skin cancer	0.000831	0.0128	CbGeAlD
Ropinirole—HTR2A—neck—skin cancer	0.000824	0.0127	CbGeAlD
Ropinirole—HTR2B—female reproductive system—skin cancer	0.00078	0.0121	CbGeAlD
Ropinirole—HTR1B—head—skin cancer	0.000724	0.0112	CbGeAlD
Ropinirole—ADRA2C—mammalian vulva—skin cancer	0.000717	0.0111	CbGeAlD
Ropinirole—HTR1D—head—skin cancer	0.000701	0.0108	CbGeAlD
Ropinirole—ADRA2A—connective tissue—skin cancer	0.000695	0.0107	CbGeAlD
Ropinirole—HTR2C—head—skin cancer	0.000694	0.0107	CbGeAlD
Ropinirole—HTR2B—head—skin cancer	0.000652	0.0101	CbGeAlD
Ropinirole—HTR2A—connective tissue—skin cancer	0.000591	0.00913	CbGeAlD
Ropinirole—HTR1A—head—skin cancer	0.000584	0.00903	CbGeAlD
Ropinirole—ADRA2A—mammalian vulva—skin cancer	0.000572	0.00884	CbGeAlD
Ropinirole—HTR2A—epithelium—skin cancer	0.000561	0.00867	CbGeAlD
Ropinirole—DRD2—head—skin cancer	0.000528	0.00816	CbGeAlD
Ropinirole—ADRA2C—head—skin cancer	0.000513	0.00793	CbGeAlD
Ropinirole—ADRA2A—female reproductive system—skin cancer	0.00049	0.00757	CbGeAlD
Ropinirole—HTR2B—lymph node—skin cancer	0.000456	0.00706	CbGeAlD
Ropinirole—HTR2A—female reproductive system—skin cancer	0.000417	0.00644	CbGeAlD
Ropinirole—ADRA2A—head—skin cancer	0.000409	0.00633	CbGeAlD
Ropinirole—CYP3A4—female reproductive system—skin cancer	0.000386	0.00596	CbGeAlD
Ropinirole—CYP2D6—female reproductive system—skin cancer	0.00038	0.00587	CbGeAlD
Ropinirole—ADRA2C—lymph node—skin cancer	0.000359	0.00555	CbGeAlD
Ropinirole—HTR2A—head—skin cancer	0.000348	0.00538	CbGeAlD
Ropinirole—CYP2D6—head—skin cancer	0.000317	0.0049	CbGeAlD
Ropinirole—ADRA2A—lymph node—skin cancer	0.000287	0.00443	CbGeAlD
Ropinirole—Dry skin—Docetaxel—skin cancer	0.000204	0.000508	CcSEcCtD
Ropinirole—Myalgia—Bleomycin—skin cancer	0.000203	0.000507	CcSEcCtD
Ropinirole—Chest pain—Bleomycin—skin cancer	0.000203	0.000507	CcSEcCtD
Ropinirole—Orthostatic hypotension—Docetaxel—skin cancer	0.000203	0.000506	CcSEcCtD
Ropinirole—Abdominal pain upper—Docetaxel—skin cancer	0.000203	0.000506	CcSEcCtD
Ropinirole—Rash—Vemurafenib—skin cancer	0.000202	0.000505	CcSEcCtD
Ropinirole—Mental disorder—Temozolomide—skin cancer	0.000202	0.000505	CcSEcCtD
Ropinirole—Dermatitis—Vemurafenib—skin cancer	0.000202	0.000505	CcSEcCtD
Ropinirole—Hypersensitivity—Imiquimod—skin cancer	0.000202	0.000504	CcSEcCtD
Ropinirole—Headache—Vemurafenib—skin cancer	0.000201	0.000502	CcSEcCtD
Ropinirole—Malnutrition—Temozolomide—skin cancer	0.000201	0.000502	CcSEcCtD
Ropinirole—Breast disorder—Docetaxel—skin cancer	0.000201	0.000501	CcSEcCtD
Ropinirole—Discomfort—Bleomycin—skin cancer	0.000201	0.000501	CcSEcCtD
Ropinirole—Malaise—Dactinomycin—skin cancer	0.0002	0.0005	CcSEcCtD
Ropinirole—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.0002	0.000499	CcSEcCtD
Ropinirole—Cramp muscle—Docetaxel—skin cancer	0.0002	0.000499	CcSEcCtD
Ropinirole—Leukopenia—Dactinomycin—skin cancer	0.000199	0.000497	CcSEcCtD
Ropinirole—Nasopharyngitis—Docetaxel—skin cancer	0.000199	0.000496	CcSEcCtD
Ropinirole—Dysgeusia—Temozolomide—skin cancer	0.000197	0.000492	CcSEcCtD
Ropinirole—Asthenia—Imiquimod—skin cancer	0.000196	0.00049	CcSEcCtD
Ropinirole—Confusional state—Bleomycin—skin cancer	0.000196	0.00049	CcSEcCtD
Ropinirole—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000196	0.000489	CcSEcCtD
Ropinirole—Oedema—Bleomycin—skin cancer	0.000195	0.000486	CcSEcCtD
Ropinirole—Back pain—Temozolomide—skin cancer	0.000194	0.000486	CcSEcCtD
Ropinirole—Pruritus—Imiquimod—skin cancer	0.000194	0.000484	CcSEcCtD
Ropinirole—Infection—Bleomycin—skin cancer	0.000193	0.000482	CcSEcCtD
Ropinirole—Dysphagia—Docetaxel—skin cancer	0.000192	0.000479	CcSEcCtD
Ropinirole—Nausea—Vemurafenib—skin cancer	0.000191	0.000476	CcSEcCtD
Ropinirole—Thrombocytopenia—Bleomycin—skin cancer	0.00019	0.000475	CcSEcCtD
Ropinirole—Arrhythmia—Fluorouracil—skin cancer	0.00019	0.000475	CcSEcCtD
Ropinirole—Vision blurred—Temozolomide—skin cancer	0.000189	0.000473	CcSEcCtD
Ropinirole—Myalgia—Dactinomycin—skin cancer	0.000189	0.000472	CcSEcCtD
Ropinirole—Tremor—Temozolomide—skin cancer	0.000188	0.00047	CcSEcCtD
Ropinirole—Alopecia—Fluorouracil—skin cancer	0.000188	0.000469	CcSEcCtD
Ropinirole—Diarrhoea—Imiquimod—skin cancer	0.000187	0.000468	CcSEcCtD
Ropinirole—Discomfort—Dactinomycin—skin cancer	0.000187	0.000467	CcSEcCtD
Ropinirole—Angina pectoris—Docetaxel—skin cancer	0.000187	0.000467	CcSEcCtD
Ropinirole—Ill-defined disorder—Temozolomide—skin cancer	0.000187	0.000466	CcSEcCtD
Ropinirole—Anaemia—Temozolomide—skin cancer	0.000186	0.000464	CcSEcCtD
Ropinirole—Anorexia—Bleomycin—skin cancer	0.000185	0.000463	CcSEcCtD
Ropinirole—Agitation—Temozolomide—skin cancer	0.000185	0.000461	CcSEcCtD
Ropinirole—Angioedema—Temozolomide—skin cancer	0.000184	0.000459	CcSEcCtD
Ropinirole—Hypotension—Bleomycin—skin cancer	0.000182	0.000454	CcSEcCtD
Ropinirole—Oedema—Dactinomycin—skin cancer	0.000181	0.000453	CcSEcCtD
Ropinirole—Malaise—Temozolomide—skin cancer	0.000181	0.000453	CcSEcCtD
Ropinirole—Dizziness—Imiquimod—skin cancer	0.000181	0.000452	CcSEcCtD
Ropinirole—Vertigo—Temozolomide—skin cancer	0.000181	0.000451	CcSEcCtD
Ropinirole—Infection—Dactinomycin—skin cancer	0.00018	0.00045	CcSEcCtD
Ropinirole—Leukopenia—Temozolomide—skin cancer	0.00018	0.000449	CcSEcCtD
Ropinirole—Palpitations—Temozolomide—skin cancer	0.000178	0.000444	CcSEcCtD
Ropinirole—Thrombocytopenia—Dactinomycin—skin cancer	0.000178	0.000443	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000177	0.000442	CcSEcCtD
Ropinirole—Cough—Temozolomide—skin cancer	0.000175	0.000438	CcSEcCtD
Ropinirole—Paraesthesia—Bleomycin—skin cancer	0.000175	0.000436	CcSEcCtD
Ropinirole—Weight increased—Docetaxel—skin cancer	0.000175	0.000436	CcSEcCtD
Ropinirole—Vision blurred—Fluorouracil—skin cancer	0.000175	0.000436	CcSEcCtD
Ropinirole—Convulsion—Temozolomide—skin cancer	0.000174	0.000435	CcSEcCtD
Ropinirole—Vomiting—Imiquimod—skin cancer	0.000174	0.000435	CcSEcCtD
Ropinirole—Weight decreased—Docetaxel—skin cancer	0.000174	0.000433	CcSEcCtD
Ropinirole—Hypertension—Temozolomide—skin cancer	0.000174	0.000433	CcSEcCtD
Ropinirole—Dyspnoea—Bleomycin—skin cancer	0.000173	0.000433	CcSEcCtD
Ropinirole—Anorexia—Dactinomycin—skin cancer	0.000173	0.000432	CcSEcCtD
Ropinirole—Rash—Imiquimod—skin cancer	0.000173	0.000431	CcSEcCtD
Ropinirole—Dermatitis—Imiquimod—skin cancer	0.000172	0.000431	CcSEcCtD
Ropinirole—Pneumonia—Docetaxel—skin cancer	0.000172	0.00043	CcSEcCtD
Ropinirole—Headache—Imiquimod—skin cancer	0.000172	0.000428	CcSEcCtD
Ropinirole—Anaemia—Fluorouracil—skin cancer	0.000171	0.000427	CcSEcCtD
Ropinirole—Arthralgia—Temozolomide—skin cancer	0.000171	0.000427	CcSEcCtD
Ropinirole—Myalgia—Temozolomide—skin cancer	0.000171	0.000427	CcSEcCtD
Ropinirole—Infestation NOS—Docetaxel—skin cancer	0.000171	0.000427	CcSEcCtD
Ropinirole—Infestation—Docetaxel—skin cancer	0.000171	0.000427	CcSEcCtD
Ropinirole—Anxiety—Temozolomide—skin cancer	0.000171	0.000426	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00017	0.000424	CcSEcCtD
Ropinirole—Discomfort—Temozolomide—skin cancer	0.000169	0.000422	CcSEcCtD
Ropinirole—Decreased appetite—Bleomycin—skin cancer	0.000169	0.000422	CcSEcCtD
Ropinirole—Acute coronary syndrome—Docetaxel—skin cancer	0.000169	0.000421	CcSEcCtD
Ropinirole—Neuropathy peripheral—Docetaxel—skin cancer	0.000168	0.000419	CcSEcCtD
Ropinirole—Myocardial infarction—Docetaxel—skin cancer	0.000168	0.000419	CcSEcCtD
Ropinirole—Dry mouth—Temozolomide—skin cancer	0.000167	0.000418	CcSEcCtD
Ropinirole—Stomatitis—Docetaxel—skin cancer	0.000167	0.000416	CcSEcCtD
Ropinirole—Pain—Bleomycin—skin cancer	0.000166	0.000415	CcSEcCtD
Ropinirole—Conjunctivitis—Docetaxel—skin cancer	0.000166	0.000415	CcSEcCtD
Ropinirole—Leukopenia—Fluorouracil—skin cancer	0.000166	0.000414	CcSEcCtD
Ropinirole—Confusional state—Temozolomide—skin cancer	0.000165	0.000413	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000165	0.000413	CcSEcCtD
Ropinirole—Oedema—Temozolomide—skin cancer	0.000164	0.00041	CcSEcCtD
Ropinirole—Infection—Temozolomide—skin cancer	0.000163	0.000407	CcSEcCtD
Ropinirole—Nausea—Imiquimod—skin cancer	0.000163	0.000406	CcSEcCtD
Ropinirole—Hepatobiliary disease—Docetaxel—skin cancer	0.000162	0.000404	CcSEcCtD
Ropinirole—Epistaxis—Docetaxel—skin cancer	0.000161	0.000403	CcSEcCtD
Ropinirole—Nervous system disorder—Temozolomide—skin cancer	0.000161	0.000402	CcSEcCtD
Ropinirole—Thrombocytopenia—Temozolomide—skin cancer	0.000161	0.000401	CcSEcCtD
Ropinirole—Convulsion—Fluorouracil—skin cancer	0.000161	0.000401	CcSEcCtD
Ropinirole—Feeling abnormal—Bleomycin—skin cancer	0.00016	0.0004	CcSEcCtD
Ropinirole—Agranulocytosis—Docetaxel—skin cancer	0.00016	0.000399	CcSEcCtD
Ropinirole—Skin disorder—Temozolomide—skin cancer	0.000159	0.000398	CcSEcCtD
Ropinirole—Hyperhidrosis—Temozolomide—skin cancer	0.000159	0.000396	CcSEcCtD
Ropinirole—Myalgia—Fluorouracil—skin cancer	0.000158	0.000394	CcSEcCtD
Ropinirole—Chest pain—Fluorouracil—skin cancer	0.000158	0.000394	CcSEcCtD
Ropinirole—Decreased appetite—Dactinomycin—skin cancer	0.000158	0.000394	CcSEcCtD
Ropinirole—Fatigue—Dactinomycin—skin cancer	0.000156	0.00039	CcSEcCtD
Ropinirole—Anorexia—Temozolomide—skin cancer	0.000156	0.00039	CcSEcCtD
Ropinirole—Discomfort—Fluorouracil—skin cancer	0.000156	0.000389	CcSEcCtD
Ropinirole—Pain—Dactinomycin—skin cancer	0.000155	0.000387	CcSEcCtD
Ropinirole—Urticaria—Bleomycin—skin cancer	0.000155	0.000386	CcSEcCtD
Ropinirole—Haemoglobin—Docetaxel—skin cancer	0.000154	0.000385	CcSEcCtD
Ropinirole—Rhinitis—Docetaxel—skin cancer	0.000154	0.000384	CcSEcCtD
Ropinirole—Body temperature increased—Bleomycin—skin cancer	0.000154	0.000384	CcSEcCtD
Ropinirole—Haemorrhage—Docetaxel—skin cancer	0.000154	0.000383	CcSEcCtD
Ropinirole—Hypoaesthesia—Docetaxel—skin cancer	0.000153	0.000382	CcSEcCtD
Ropinirole—Confusional state—Fluorouracil—skin cancer	0.000152	0.000381	CcSEcCtD
Ropinirole—Pharyngitis—Docetaxel—skin cancer	0.000152	0.000381	CcSEcCtD
Ropinirole—Urinary tract disorder—Docetaxel—skin cancer	0.000152	0.000379	CcSEcCtD
Ropinirole—Oedema peripheral—Docetaxel—skin cancer	0.000151	0.000378	CcSEcCtD
Ropinirole—Oedema—Fluorouracil—skin cancer	0.000151	0.000377	CcSEcCtD
Ropinirole—Connective tissue disorder—Docetaxel—skin cancer	0.000151	0.000377	CcSEcCtD
Ropinirole—Urethral disorder—Docetaxel—skin cancer	0.000151	0.000376	CcSEcCtD
Ropinirole—Infection—Fluorouracil—skin cancer	0.00015	0.000375	CcSEcCtD
Ropinirole—Feeling abnormal—Dactinomycin—skin cancer	0.00015	0.000373	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00015	0.000373	CcSEcCtD
Ropinirole—Insomnia—Temozolomide—skin cancer	0.000148	0.000371	CcSEcCtD
Ropinirole—Gastrointestinal pain—Dactinomycin—skin cancer	0.000148	0.00037	CcSEcCtD
Ropinirole—Nervous system disorder—Fluorouracil—skin cancer	0.000148	0.00037	CcSEcCtD
Ropinirole—Thrombocytopenia—Fluorouracil—skin cancer	0.000148	0.00037	CcSEcCtD
Ropinirole—Visual impairment—Docetaxel—skin cancer	0.000148	0.00037	CcSEcCtD
Ropinirole—Tachycardia—Fluorouracil—skin cancer	0.000148	0.000368	CcSEcCtD
Ropinirole—Paraesthesia—Temozolomide—skin cancer	0.000147	0.000368	CcSEcCtD
Ropinirole—Dyspnoea—Temozolomide—skin cancer	0.000146	0.000365	CcSEcCtD
Ropinirole—Somnolence—Temozolomide—skin cancer	0.000146	0.000364	CcSEcCtD
Ropinirole—Dyspepsia—Temozolomide—skin cancer	0.000144	0.000361	CcSEcCtD
Ropinirole—Anorexia—Fluorouracil—skin cancer	0.000144	0.00036	CcSEcCtD
Ropinirole—Eye disorder—Docetaxel—skin cancer	0.000144	0.000358	CcSEcCtD
Ropinirole—Body temperature increased—Dactinomycin—skin cancer	0.000143	0.000358	CcSEcCtD
Ropinirole—Abdominal pain—Dactinomycin—skin cancer	0.000143	0.000358	CcSEcCtD
Ropinirole—Hypersensitivity—Bleomycin—skin cancer	0.000143	0.000358	CcSEcCtD
Ropinirole—Decreased appetite—Temozolomide—skin cancer	0.000143	0.000356	CcSEcCtD
Ropinirole—Flushing—Docetaxel—skin cancer	0.000143	0.000356	CcSEcCtD
Ropinirole—Cardiac disorder—Docetaxel—skin cancer	0.000143	0.000356	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Temozolomide—skin cancer	0.000142	0.000354	CcSEcCtD
Ropinirole—Fatigue—Temozolomide—skin cancer	0.000141	0.000353	CcSEcCtD
Ropinirole—Hypotension—Fluorouracil—skin cancer	0.000141	0.000353	CcSEcCtD
Ropinirole—Pain—Temozolomide—skin cancer	0.00014	0.00035	CcSEcCtD
Ropinirole—Constipation—Temozolomide—skin cancer	0.00014	0.00035	CcSEcCtD
Ropinirole—Asthenia—Bleomycin—skin cancer	0.00014	0.000348	CcSEcCtD
Ropinirole—Angiopathy—Docetaxel—skin cancer	0.000139	0.000348	CcSEcCtD
Ropinirole—Immune system disorder—Docetaxel—skin cancer	0.000139	0.000346	CcSEcCtD
Ropinirole—Mediastinal disorder—Docetaxel—skin cancer	0.000138	0.000346	CcSEcCtD
Ropinirole—Chills—Docetaxel—skin cancer	0.000138	0.000344	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000138	0.000344	CcSEcCtD
Ropinirole—Pruritus—Bleomycin—skin cancer	0.000138	0.000344	CcSEcCtD
Ropinirole—Arrhythmia—Docetaxel—skin cancer	0.000137	0.000343	CcSEcCtD
Ropinirole—Insomnia—Fluorouracil—skin cancer	0.000137	0.000341	CcSEcCtD
Ropinirole—Paraesthesia—Fluorouracil—skin cancer	0.000136	0.000339	CcSEcCtD
Ropinirole—Alopecia—Docetaxel—skin cancer	0.000136	0.000339	CcSEcCtD
Ropinirole—Feeling abnormal—Temozolomide—skin cancer	0.000135	0.000338	CcSEcCtD
Ropinirole—Dyspnoea—Fluorouracil—skin cancer	0.000135	0.000337	CcSEcCtD
Ropinirole—Mental disorder—Docetaxel—skin cancer	0.000135	0.000336	CcSEcCtD
Ropinirole—Somnolence—Fluorouracil—skin cancer	0.000134	0.000336	CcSEcCtD
Ropinirole—Gastrointestinal pain—Temozolomide—skin cancer	0.000134	0.000335	CcSEcCtD
Ropinirole—Malnutrition—Docetaxel—skin cancer	0.000134	0.000334	CcSEcCtD
Ropinirole—Hypersensitivity—Dactinomycin—skin cancer	0.000134	0.000334	CcSEcCtD
Ropinirole—Dyspepsia—Fluorouracil—skin cancer	0.000133	0.000332	CcSEcCtD
Ropinirole—Decreased appetite—Fluorouracil—skin cancer	0.000131	0.000328	CcSEcCtD
Ropinirole—Dysgeusia—Docetaxel—skin cancer	0.000131	0.000327	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000131	0.000326	CcSEcCtD
Ropinirole—Urticaria—Temozolomide—skin cancer	0.00013	0.000325	CcSEcCtD
Ropinirole—Asthenia—Dactinomycin—skin cancer	0.00013	0.000325	CcSEcCtD
Ropinirole—Body temperature increased—Temozolomide—skin cancer	0.00013	0.000324	CcSEcCtD
Ropinirole—Abdominal pain—Temozolomide—skin cancer	0.00013	0.000324	CcSEcCtD
Ropinirole—Back pain—Docetaxel—skin cancer	0.000129	0.000323	CcSEcCtD
Ropinirole—Pain—Fluorouracil—skin cancer	0.000129	0.000323	CcSEcCtD
Ropinirole—Muscle spasms—Docetaxel—skin cancer	0.000129	0.000321	CcSEcCtD
Ropinirole—Feeling abnormal—Fluorouracil—skin cancer	0.000125	0.000311	CcSEcCtD
Ropinirole—Diarrhoea—Dactinomycin—skin cancer	0.000124	0.00031	CcSEcCtD
Ropinirole—Vomiting—Bleomycin—skin cancer	0.000124	0.000309	CcSEcCtD
Ropinirole—Anaemia—Docetaxel—skin cancer	0.000124	0.000309	CcSEcCtD
Ropinirole—Rash—Bleomycin—skin cancer	0.000123	0.000306	CcSEcCtD
Ropinirole—Dermatitis—Bleomycin—skin cancer	0.000123	0.000306	CcSEcCtD
Ropinirole—Hypersensitivity—Temozolomide—skin cancer	0.000121	0.000302	CcSEcCtD
Ropinirole—Urticaria—Fluorouracil—skin cancer	0.00012	0.0003	CcSEcCtD
Ropinirole—Syncope—Docetaxel—skin cancer	0.00012	0.000299	CcSEcCtD
Ropinirole—Leukopenia—Docetaxel—skin cancer	0.00012	0.000299	CcSEcCtD
Ropinirole—Body temperature increased—Fluorouracil—skin cancer	0.00012	0.000298	CcSEcCtD
Ropinirole—Palpitations—Docetaxel—skin cancer	0.000118	0.000295	CcSEcCtD
Ropinirole—Asthenia—Temozolomide—skin cancer	0.000118	0.000294	CcSEcCtD
Ropinirole—Loss of consciousness—Docetaxel—skin cancer	0.000118	0.000293	CcSEcCtD
Ropinirole—Cough—Docetaxel—skin cancer	0.000117	0.000291	CcSEcCtD
Ropinirole—Pruritus—Temozolomide—skin cancer	0.000116	0.00029	CcSEcCtD
Ropinirole—Convulsion—Docetaxel—skin cancer	0.000116	0.000289	CcSEcCtD
Ropinirole—Nausea—Bleomycin—skin cancer	0.000116	0.000288	CcSEcCtD
Ropinirole—Hypertension—Docetaxel—skin cancer	0.000115	0.000288	CcSEcCtD
Ropinirole—Vomiting—Dactinomycin—skin cancer	0.000115	0.000288	CcSEcCtD
Ropinirole—Rash—Dactinomycin—skin cancer	0.000114	0.000286	CcSEcCtD
Ropinirole—Myalgia—Docetaxel—skin cancer	0.000114	0.000284	CcSEcCtD
Ropinirole—Arthralgia—Docetaxel—skin cancer	0.000114	0.000284	CcSEcCtD
Ropinirole—Chest pain—Docetaxel—skin cancer	0.000114	0.000284	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000113	0.000282	CcSEcCtD
Ropinirole—Diarrhoea—Temozolomide—skin cancer	0.000112	0.00028	CcSEcCtD
Ropinirole—Hypersensitivity—Fluorouracil—skin cancer	0.000111	0.000278	CcSEcCtD
Ropinirole—Dry mouth—Docetaxel—skin cancer	0.000111	0.000278	CcSEcCtD
Ropinirole—Confusional state—Docetaxel—skin cancer	0.00011	0.000275	CcSEcCtD
Ropinirole—Oedema—Docetaxel—skin cancer	0.000109	0.000272	CcSEcCtD
Ropinirole—Dizziness—Temozolomide—skin cancer	0.000109	0.000271	CcSEcCtD
Ropinirole—Infection—Docetaxel—skin cancer	0.000108	0.000271	CcSEcCtD
Ropinirole—Nausea—Dactinomycin—skin cancer	0.000108	0.000269	CcSEcCtD
Ropinirole—Shock—Docetaxel—skin cancer	0.000107	0.000268	CcSEcCtD
Ropinirole—Nervous system disorder—Docetaxel—skin cancer	0.000107	0.000267	CcSEcCtD
Ropinirole—Pruritus—Fluorouracil—skin cancer	0.000107	0.000267	CcSEcCtD
Ropinirole—Thrombocytopenia—Docetaxel—skin cancer	0.000107	0.000267	CcSEcCtD
Ropinirole—Tachycardia—Docetaxel—skin cancer	0.000107	0.000266	CcSEcCtD
Ropinirole—Skin disorder—Docetaxel—skin cancer	0.000106	0.000265	CcSEcCtD
Ropinirole—Vomiting—Temozolomide—skin cancer	0.000104	0.00026	CcSEcCtD
Ropinirole—Anorexia—Docetaxel—skin cancer	0.000104	0.00026	CcSEcCtD
Ropinirole—Rash—Temozolomide—skin cancer	0.000103	0.000258	CcSEcCtD
Ropinirole—Diarrhoea—Fluorouracil—skin cancer	0.000103	0.000258	CcSEcCtD
Ropinirole—Dermatitis—Temozolomide—skin cancer	0.000103	0.000258	CcSEcCtD
Ropinirole—Headache—Temozolomide—skin cancer	0.000103	0.000257	CcSEcCtD
Ropinirole—Hypotension—Docetaxel—skin cancer	0.000102	0.000255	CcSEcCtD
Ropinirole—Dizziness—Fluorouracil—skin cancer	0.0001	0.00025	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Docetaxel—skin cancer	9.94e-05	0.000248	CcSEcCtD
Ropinirole—Insomnia—Docetaxel—skin cancer	9.87e-05	0.000246	CcSEcCtD
Ropinirole—Paraesthesia—Docetaxel—skin cancer	9.8e-05	0.000245	CcSEcCtD
Ropinirole—Nausea—Temozolomide—skin cancer	9.75e-05	0.000243	CcSEcCtD
Ropinirole—Dyspnoea—Docetaxel—skin cancer	9.73e-05	0.000243	CcSEcCtD
Ropinirole—Somnolence—Docetaxel—skin cancer	9.7e-05	0.000242	CcSEcCtD
Ropinirole—Vomiting—Fluorouracil—skin cancer	9.61e-05	0.00024	CcSEcCtD
Ropinirole—Dyspepsia—Docetaxel—skin cancer	9.61e-05	0.00024	CcSEcCtD
Ropinirole—Rash—Fluorouracil—skin cancer	9.53e-05	0.000238	CcSEcCtD
Ropinirole—Dermatitis—Fluorouracil—skin cancer	9.52e-05	0.000238	CcSEcCtD
Ropinirole—Decreased appetite—Docetaxel—skin cancer	9.49e-05	0.000237	CcSEcCtD
Ropinirole—Headache—Fluorouracil—skin cancer	9.47e-05	0.000236	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Docetaxel—skin cancer	9.42e-05	0.000235	CcSEcCtD
Ropinirole—Fatigue—Docetaxel—skin cancer	9.41e-05	0.000235	CcSEcCtD
Ropinirole—Pain—Docetaxel—skin cancer	9.33e-05	0.000233	CcSEcCtD
Ropinirole—Constipation—Docetaxel—skin cancer	9.33e-05	0.000233	CcSEcCtD
Ropinirole—Feeling abnormal—Docetaxel—skin cancer	8.99e-05	0.000224	CcSEcCtD
Ropinirole—Nausea—Fluorouracil—skin cancer	8.98e-05	0.000224	CcSEcCtD
Ropinirole—Gastrointestinal pain—Docetaxel—skin cancer	8.92e-05	0.000223	CcSEcCtD
Ropinirole—Abdominal pain—Docetaxel—skin cancer	8.63e-05	0.000215	CcSEcCtD
Ropinirole—Body temperature increased—Docetaxel—skin cancer	8.63e-05	0.000215	CcSEcCtD
Ropinirole—Hypersensitivity—Docetaxel—skin cancer	8.04e-05	0.000201	CcSEcCtD
Ropinirole—Asthenia—Docetaxel—skin cancer	7.83e-05	0.000195	CcSEcCtD
Ropinirole—Pruritus—Docetaxel—skin cancer	7.72e-05	0.000193	CcSEcCtD
Ropinirole—Diarrhoea—Docetaxel—skin cancer	7.47e-05	0.000186	CcSEcCtD
Ropinirole—Dizziness—Docetaxel—skin cancer	7.22e-05	0.00018	CcSEcCtD
Ropinirole—Vomiting—Docetaxel—skin cancer	6.94e-05	0.000173	CcSEcCtD
Ropinirole—Rash—Docetaxel—skin cancer	6.88e-05	0.000172	CcSEcCtD
Ropinirole—Dermatitis—Docetaxel—skin cancer	6.87e-05	0.000172	CcSEcCtD
Ropinirole—Headache—Docetaxel—skin cancer	6.84e-05	0.000171	CcSEcCtD
Ropinirole—Nausea—Docetaxel—skin cancer	6.48e-05	0.000162	CcSEcCtD
Ropinirole—HTR2A—Signaling Pathways—SUFU—skin cancer	1.79e-05	0.0007	CbGpPWpGaD
Ropinirole—DRD2—Circadian rythm related genes—TP53—skin cancer	1.77e-05	0.000695	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PLIN2—skin cancer	1.77e-05	0.000691	CbGpPWpGaD
Ropinirole—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	1.74e-05	0.000683	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MC1R—skin cancer	1.74e-05	0.000682	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PTCH1—skin cancer	1.74e-05	0.000681	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—SMO—skin cancer	1.74e-05	0.000681	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—FOXO4—skin cancer	1.73e-05	0.000676	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—SMO—skin cancer	1.72e-05	0.000672	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PTCH1—skin cancer	1.72e-05	0.000672	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—GLI1—skin cancer	1.72e-05	0.000672	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PTGER4—skin cancer	1.7e-05	0.000663	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—FOXO4—skin cancer	1.69e-05	0.000661	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PTGER4—skin cancer	1.67e-05	0.000655	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—FOXO4—skin cancer	1.66e-05	0.000651	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—SHH—skin cancer	1.64e-05	0.00064	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SUFU—skin cancer	1.63e-05	0.000637	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—RASA1—skin cancer	1.63e-05	0.000636	CbGpPWpGaD
Ropinirole—DRD2—Circadian rythm related genes—IL6—skin cancer	1.62e-05	0.000636	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—FOXO4—skin cancer	1.59e-05	0.000621	CbGpPWpGaD
Ropinirole—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	1.58e-05	0.000619	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—SHH—skin cancer	1.58e-05	0.000618	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—SHH—skin cancer	1.57e-05	0.000615	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—RASA1—skin cancer	1.57e-05	0.000614	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—RASA1—skin cancer	1.56e-05	0.000611	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—SMO—skin cancer	1.55e-05	0.000607	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PTCH1—skin cancer	1.55e-05	0.000607	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—SHH—skin cancer	1.53e-05	0.000598	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—RASA1—skin cancer	1.52e-05	0.000594	CbGpPWpGaD
Ropinirole—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	1.51e-05	0.000593	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PTGER4—skin cancer	1.51e-05	0.000591	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—TERT—skin cancer	1.51e-05	0.000589	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—FOXO4—skin cancer	1.5e-05	0.000586	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—SMO—skin cancer	1.5e-05	0.000586	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PTCH1—skin cancer	1.5e-05	0.000586	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PLIN2—skin cancer	1.5e-05	0.000585	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PTCH1—skin cancer	1.49e-05	0.000583	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—SMO—skin cancer	1.49e-05	0.000583	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—ENO2—skin cancer	1.48e-05	0.000581	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—FOXO4—skin cancer	1.48e-05	0.000578	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PTGER4—skin cancer	1.46e-05	0.00057	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PTGER4—skin cancer	1.45e-05	0.000568	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PTCH1—skin cancer	1.45e-05	0.000567	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—SMO—skin cancer	1.45e-05	0.000567	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CSPG4—skin cancer	1.42e-05	0.000557	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PTGER4—skin cancer	1.41e-05	0.000552	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—SHH—skin cancer	1.39e-05	0.000543	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—RASA1—skin cancer	1.38e-05	0.000539	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—SHH—skin cancer	1.36e-05	0.000534	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—RASA1—skin cancer	1.36e-05	0.000531	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—FOXO4—skin cancer	1.33e-05	0.000522	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PTCH1—skin cancer	1.31e-05	0.000514	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—SMO—skin cancer	1.31e-05	0.000514	CbGpPWpGaD
Ropinirole—ADRA2B—Hemostasis—NRAS—skin cancer	1.31e-05	0.000512	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PTCH1—skin cancer	1.29e-05	0.000506	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—SMO—skin cancer	1.29e-05	0.000506	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—FOXO4—skin cancer	1.29e-05	0.000504	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—FOXO4—skin cancer	1.28e-05	0.000501	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PTGER4—skin cancer	1.28e-05	0.000501	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—NRAS—skin cancer	1.27e-05	0.000496	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PTGER4—skin cancer	1.26e-05	0.000493	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—FOXO4—skin cancer	1.25e-05	0.000488	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SHH—skin cancer	1.24e-05	0.000486	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—RASA1—skin cancer	1.23e-05	0.000483	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—NRAS—skin cancer	1.22e-05	0.000478	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CSPG4—skin cancer	1.21e-05	0.000472	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—BRAF—skin cancer	1.19e-05	0.000466	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SMO—skin cancer	1.18e-05	0.000461	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PTCH1—skin cancer	1.18e-05	0.000461	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PLIN2—skin cancer	1.15e-05	0.000452	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TERT—skin cancer	1.15e-05	0.000451	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PTGER4—skin cancer	1.15e-05	0.000448	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—FOXO4—skin cancer	1.13e-05	0.000442	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TERT—skin cancer	1.13e-05	0.000442	CbGpPWpGaD
Ropinirole—ADRA2B—Hemostasis—KRAS—skin cancer	1.13e-05	0.000441	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—FOXO4—skin cancer	1.11e-05	0.000435	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TERT—skin cancer	1.11e-05	0.000435	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—KRAS—skin cancer	1.09e-05	0.000427	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—ERCC2—skin cancer	1.06e-05	0.000415	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TERT—skin cancer	1.06e-05	0.000415	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—KRAS—skin cancer	1.05e-05	0.000411	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—FOXO4—skin cancer	1.01e-05	0.000396	CbGpPWpGaD
Ropinirole—ADRA2B—Hemostasis—TP53—skin cancer	1e-05	0.000392	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TERT—skin cancer	1e-05	0.000391	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—NRAS—skin cancer	9.92e-06	0.000388	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TERT—skin cancer	9.87e-06	0.000386	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—NRAS—skin cancer	9.72e-06	0.00038	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ENO2—skin cancer	9.68e-06	0.000379	CbGpPWpGaD
Ropinirole—ADRA2B—Hemostasis—HRAS—skin cancer	9.57e-06	0.000374	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—NRAS—skin cancer	9.51e-06	0.000372	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—NRAS—skin cancer	9.36e-06	0.000366	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—TP53—skin cancer	9.35e-06	0.000366	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CSPG4—skin cancer	9.31e-06	0.000364	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—HRAS—skin cancer	9.28e-06	0.000363	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—BRAF—skin cancer	9.13e-06	0.000357	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—BRAF—skin cancer	8.94e-06	0.00035	CbGpPWpGaD
Ropinirole—ADRA2C—Hemostasis—HRAS—skin cancer	8.94e-06	0.00035	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—NRAS—skin cancer	8.94e-06	0.00035	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TERT—skin cancer	8.91e-06	0.000349	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—IL6—skin cancer	8.88e-06	0.000347	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—BRAF—skin cancer	8.8e-06	0.000344	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—ERCC2—skin cancer	8.62e-06	0.000337	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TERT—skin cancer	8.6e-06	0.000337	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TERT—skin cancer	8.56e-06	0.000335	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—KRAS—skin cancer	8.54e-06	0.000334	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—NRAS—skin cancer	8.43e-06	0.00033	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—BRAF—skin cancer	8.4e-06	0.000329	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—KRAS—skin cancer	8.36e-06	0.000327	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TERT—skin cancer	8.32e-06	0.000326	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—NRAS—skin cancer	8.31e-06	0.000325	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ENO2—skin cancer	8.2e-06	0.000321	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—KRAS—skin cancer	8.19e-06	0.00032	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—KRAS—skin cancer	8.06e-06	0.000315	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—BRAF—skin cancer	7.92e-06	0.00031	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—BRAF—skin cancer	7.82e-06	0.000306	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—KRAS—skin cancer	7.69e-06	0.000301	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—TP53—skin cancer	7.59e-06	0.000297	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TERT—skin cancer	7.55e-06	0.000295	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—NRAS—skin cancer	7.51e-06	0.000294	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—NRAS—skin cancer	7.49e-06	0.000293	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TERT—skin cancer	7.43e-06	0.000291	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—HRAS—skin cancer	7.26e-06	0.000284	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—KRAS—skin cancer	7.25e-06	0.000284	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—NRAS—skin cancer	7.25e-06	0.000284	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—NRAS—skin cancer	7.21e-06	0.000282	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—KRAS—skin cancer	7.16e-06	0.00028	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—HRAS—skin cancer	7.11e-06	0.000278	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—BRAF—skin cancer	7.06e-06	0.000276	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—NRAS—skin cancer	7.01e-06	0.000274	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—HRAS—skin cancer	6.96e-06	0.000272	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—HRAS—skin cancer	6.85e-06	0.000268	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—BRAF—skin cancer	6.81e-06	0.000267	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—IL6—skin cancer	6.8e-06	0.000266	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—BRAF—skin cancer	6.78e-06	0.000265	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TERT—skin cancer	6.76e-06	0.000265	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—IL6—skin cancer	6.66e-06	0.000261	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—BRAF—skin cancer	6.59e-06	0.000258	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—IL6—skin cancer	6.55e-06	0.000256	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—HRAS—skin cancer	6.54e-06	0.000256	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—KRAS—skin cancer	6.46e-06	0.000253	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—KRAS—skin cancer	6.45e-06	0.000252	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.41e-06	0.000251	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PTGS2—skin cancer	6.37e-06	0.000249	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—NRAS—skin cancer	6.36e-06	0.000249	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ENO2—skin cancer	6.33e-06	0.000248	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—NRAS—skin cancer	6.26e-06	0.000245	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—IL6—skin cancer	6.26e-06	0.000245	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—KRAS—skin cancer	6.24e-06	0.000244	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—KRAS—skin cancer	6.2e-06	0.000243	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—HRAS—skin cancer	6.17e-06	0.000241	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—HRAS—skin cancer	6.08e-06	0.000238	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—KRAS—skin cancer	6.04e-06	0.000236	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—BRAF—skin cancer	5.98e-06	0.000234	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—IL6—skin cancer	5.9e-06	0.000231	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—BRAF—skin cancer	5.88e-06	0.00023	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—IL6—skin cancer	5.82e-06	0.000228	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—NRAS—skin cancer	5.74e-06	0.000225	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—TP53—skin cancer	5.73e-06	0.000224	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—NRAS—skin cancer	5.7e-06	0.000223	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ERCC2—skin cancer	5.62e-06	0.00022	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—NRAS—skin cancer	5.62e-06	0.00022	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—NRAS—skin cancer	5.53e-06	0.000216	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—HRAS—skin cancer	5.49e-06	0.000215	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—HRAS—skin cancer	5.48e-06	0.000214	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—KRAS—skin cancer	5.48e-06	0.000214	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—KRAS—skin cancer	5.39e-06	0.000211	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—BRAF—skin cancer	5.35e-06	0.000209	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—HRAS—skin cancer	5.3e-06	0.000207	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—NRAS—skin cancer	5.28e-06	0.000207	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—HRAS—skin cancer	5.27e-06	0.000206	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—IL6—skin cancer	5.26e-06	0.000206	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—IL6—skin cancer	5.25e-06	0.000205	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTGS2—skin cancer	5.17e-06	0.000202	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—HRAS—skin cancer	5.13e-06	0.000201	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—IL6—skin cancer	5.07e-06	0.000199	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—IL6—skin cancer	5.05e-06	0.000198	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—NRAS—skin cancer	4.98e-06	0.000195	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—KRAS—skin cancer	4.94e-06	0.000193	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—NRAS—skin cancer	4.91e-06	0.000192	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—IL6—skin cancer	4.91e-06	0.000192	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—KRAS—skin cancer	4.9e-06	0.000192	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—KRAS—skin cancer	4.84e-06	0.000189	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ERCC2—skin cancer	4.76e-06	0.000186	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—KRAS—skin cancer	4.76e-06	0.000186	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—HRAS—skin cancer	4.65e-06	0.000182	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—HRAS—skin cancer	4.58e-06	0.000179	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—KRAS—skin cancer	4.54e-06	0.000178	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—IL6—skin cancer	4.45e-06	0.000174	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—NRAS—skin cancer	4.43e-06	0.000174	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TP53—skin cancer	4.39e-06	0.000172	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—IL6—skin cancer	4.38e-06	0.000172	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TP53—skin cancer	4.3e-06	0.000168	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—KRAS—skin cancer	4.28e-06	0.000168	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—NRAS—skin cancer	4.28e-06	0.000168	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—NRAS—skin cancer	4.26e-06	0.000167	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TP53—skin cancer	4.23e-06	0.000166	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—KRAS—skin cancer	4.23e-06	0.000165	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—HRAS—skin cancer	4.2e-06	0.000164	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—HRAS—skin cancer	4.17e-06	0.000163	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—NRAS—skin cancer	4.14e-06	0.000162	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—HRAS—skin cancer	4.11e-06	0.000161	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—HRAS—skin cancer	4.05e-06	0.000158	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TP53—skin cancer	4.04e-06	0.000158	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—IL6—skin cancer	4.02e-06	0.000157	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—IL6—skin cancer	3.99e-06	0.000156	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—IL6—skin cancer	3.93e-06	0.000154	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—IL6—skin cancer	3.87e-06	0.000152	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—HRAS—skin cancer	3.86e-06	0.000151	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—KRAS—skin cancer	3.82e-06	0.000149	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TP53—skin cancer	3.81e-06	0.000149	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NRAS—skin cancer	3.76e-06	0.000147	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TP53—skin cancer	3.76e-06	0.000147	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NRAS—skin cancer	3.7e-06	0.000145	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL6—skin cancer	3.7e-06	0.000145	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—KRAS—skin cancer	3.68e-06	0.000144	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ERCC2—skin cancer	3.67e-06	0.000144	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—KRAS—skin cancer	3.67e-06	0.000143	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—HRAS—skin cancer	3.64e-06	0.000143	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—HRAS—skin cancer	3.59e-06	0.000141	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—KRAS—skin cancer	3.57e-06	0.00014	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL6—skin cancer	3.49e-06	0.000136	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL6—skin cancer	3.44e-06	0.000135	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TP53—skin cancer	3.39e-06	0.000133	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTGS2—skin cancer	3.37e-06	0.000132	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NRAS—skin cancer	3.36e-06	0.000132	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TP53—skin cancer	3.27e-06	0.000128	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TP53—skin cancer	3.26e-06	0.000127	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—HRAS—skin cancer	3.24e-06	0.000127	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—KRAS—skin cancer	3.23e-06	0.000127	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—KRAS—skin cancer	3.18e-06	0.000125	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TP53—skin cancer	3.17e-06	0.000124	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—HRAS—skin cancer	3.13e-06	0.000123	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—HRAS—skin cancer	3.12e-06	0.000122	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL6—skin cancer	3.11e-06	0.000121	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—HRAS—skin cancer	3.03e-06	0.000119	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL6—skin cancer	3e-06	0.000117	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL6—skin cancer	2.98e-06	0.000117	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL6—skin cancer	2.9e-06	0.000113	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KRAS—skin cancer	2.9e-06	0.000113	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TP53—skin cancer	2.88e-06	0.000113	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTGS2—skin cancer	2.85e-06	0.000112	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TP53—skin cancer	2.83e-06	0.000111	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HRAS—skin cancer	2.75e-06	0.000108	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—HRAS—skin cancer	2.71e-06	0.000106	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL6—skin cancer	2.63e-06	0.000103	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL6—skin cancer	2.59e-06	0.000101	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TP53—skin cancer	2.57e-06	0.000101	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HRAS—skin cancer	2.46e-06	9.63e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL6—skin cancer	2.36e-06	9.22e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTGS2—skin cancer	2.2e-06	8.62e-05	CbGpPWpGaD
